DUALVIII: more patients met treatment targets with IDegLira (insulin degludec/liraglutide) vs IGlar U100 by week 26 in a 104 week randomised trial mirroring clinical practice

---

Copy For Citation

Sesti G., Bardtrum L., Daddelen S., Halladin N., Haluzik M., Orsy P., ...More

55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Barcelona, Spain, 16 - 20 September 2019, vol.62

• Publication Type: Conference Paper / Summary Text
• Volume: 62
• City: Barcelona
• Country: Spain
• Hacettepe University Affiliated: Yes